Company intelligence / Profile preview

Diagnostics Research Group

San Antonio, Texas, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Diagnostics Research Group is a San Antonio-based clinical research site and flexible trial network providing Phase II–IV site-based, hybrid, and decentralized clinical trial services across multiple therapeutic areas; it does not have its own drug pipeline but runs sponsor-funded trials, and was acquired by The IMA Group in 2021 while continuing operations under its existing name.

Therapeutic areas: ImmunologyOtherInfectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculeBiologicVaccineMedical device
Industry: Contract Research Organization

Partnerships

Sponsors of Phase II–IV pharmaceutical and medical device trials (various; not individually named in sources)

Beyond the preview

Go deeper on Diagnostics Research Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnostics Research Group.

Explore the full profile